Dr. Frischwasser Deuch Salomon

Cardiólogo

User Image

Edificio Medicentro La Sabana
Sobre el Boulevard de Rohrmoser, 150 metros oeste del Scotiabank, San José

Estudios Superiores

  • Medical Doctor Dec. 1975 University of Costa Rica
  • Cardiologist Dec. 1980 University of Costa Rica
  • Fellowship in Cardiology Dec/1982 Baylor College Houston Texas
  • Asesor latinoamericano para las sociedades de Ecocardiografía.

Asociaciones

  • Asociación Costarricense Cardiovascular
  • Asociación Costarricense de Arteriosclerosis
  • CLACC. Consejo latinoamericano para el cuidado cardiovascular

Experiencia Profesional

  • 1985-2019 Attending Physician in Cardiology And Director of Echocardiography Laboratory San Juan de Dios Hospital, Costa Rica.
  • 2000-2022 Attending Physician in Cardiology And Honorary Doctor of the Cima Hospital Medical Staff Hospital CIMA San José, Costa Rica.
  • 1988-1989 Past president of The Costarrican Society of Cardiology Costarrican Society of Cardiology.
  • 1986-2005 Chief of The Echocardiography Laboratory of San Juan de Dios Hospital San Juan de Dios Hospital, Costa Rica.
  • 1990-2005 Member of Pharmacotherapy Committee of Social Security System in Costa Rica Pharmacotherapy Committee, Costa Rica.

Investigación Clínica

  • Principal Investigator in Losartan Trial in failure Heart. MSD Laboratory.
  • Rol of the echocardiography in the valvular heart surgery without previous cath.
  • Rol of the TEE Echo in the Diagnosis of Acute Aortic Aneurism.
  • Cardiologist in a multicenter double  blind, placebo controlled study to evaluate the safety and efficacy of Protocol 035 MK-0431 to patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on glimepiride alone or in combination with metformin.
  • Postmenopausal Evaluation and Risks reduction with Lasofoxifene. Cardiologist. 2002-2007.
  • A two- years study to asses the safety, tolerability and efficacy of MK-0364 in obese patients. Cardiologist. 2006-2008.
  • A multicenter , randomized, double blind study to evaluate the safety and efficacy of Protocol 064 MK 0431 as the initial therapy with coadministration of sitagliptine and pioglitazone in patients type 2 Diabetes Mellitus. Cardiologist 2007-2008.
  • Cardiologist in protocol 007 MK0941 Merck Sharp and Dohme. 2009-2014.
  • Principal Investigator in in protocol CSPA100A2307. Novartis. 2009 -2014.